TOWN HEALTH3886.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, TOWN HEALTH (3886.HK) trades at a P/E of 75.00x, P/B of 0.36x, P/S of 0.62x, and a dividend yield of 1.12%.
Longitudinal percentile comparison: P/E sits at the 13th percentile over the trailing 10Y window (vs. 26th percentile over 3Y); P/B sits at the 1st percentile over the trailing 10Y window (vs. 2nd percentile over 3Y); P/S sits at the 1st percentile over the trailing 10Y window (vs. 2nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 89th percentile within its industry and the 93rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.12%, ranking at the 68th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 12.2 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. TOWN HEALTH operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 3886 · SEHK: 3886 · 3886
Want the full picture on whether TOWN HEALTH (3886.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 75.00 | ||||||
| P/B (MRQ) | 0.36 | ||||||
| P/S (TTM) | 0.62 | ||||||
| Dividend Yield | 1.12% | ||||||
| Buyback + Div Yield | 1.12% |